Healium Medical

Healium Medical

Yokneam, Israel· Est.

Healium offers contact‑free ultrasound catheter ablation for atrial fibrillation and renal denervation, leveraging real‑time imaging and automated power control.

Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Estimated funding: $5M

AI Company Overview

Healium offers contact‑free ultrasound catheter ablation for atrial fibrillation and renal denervation, leveraging real‑time imaging and automated power control.

CardiovascularElectrophysiology

Technology Platform

Dual‑Mode Ultrasound Technology (DMUT) integrates intravascular imaging with therapeutic ultrasound to enable non‑contact, real‑time lesion creation and automated power titration based on tissue thickness.

Opportunities

Healium can capture a growing share of the $58 B cardiac ablation market by offering a contact‑free, image‑guided solution that reduces procedure time and repeat interventions, and by expanding into the emerging renal denervation space.

Risk Factors

Key risks include achieving regulatory clearance, demonstrating clinical superiority over established RF and cryo technologies, and securing reimbursement pathways in major markets.

Competitive Landscape

Main competitors are Medtronic, Abbott, and Boston Scientific, which dominate RF and cryo ablation; Healium differentiates through non‑contact ultrasound delivery and real‑time lesion monitoring.